Background: Nuclear localizing b-galactosidase (nlsb-gal) is used as a marker for studying myoblast cell lineage and for evaluating myoblast survival after myoblast transfer, a procedure with potential use for gene complementation for muscular dystrophy. Usefulness of this construct depends on the establishment of the extent to which nlsb-gal or its mRNA may be translocated from the nucleus that encodes it to other non-coding myonuclei in hybrid myofibers and the ease with which the encoding and non-coding myonuclei can be distinguished. Previous in vitro studies (Ralston and Hall 1989. Science, 244:1066-1068) have suggested limited translocation of the fusion protein. We re-examined the extent to which nlsb-gal is translocated in hybrid myofibers, both in vitro and in vivo, and evaluated the extent to which one can rely on histochemistry to distinguish encoding from non-coding nuclei in these myofibers.Methods: Myotubes formed in co-cultures of a myoblast line (MM14 cells), stably transfected with a construct consisting of a nlsb-gal under the control of the myosin light chain 3F promoter and 38 enhancer (3FlacZ10 cells), and [3H]-thymidine-labeled parental MM14 cells (plated at ratios of 1:6 or 1:20, respectively) were reacted with X-gal. After autoradiography, the distance over which nlsb-gal was translocated in hybrid myotubes was determined. In vivo translocation of nlsb-gal was evaluated by injecting [3H]-thymidine-labeled 3FlacZ10 myoblasts into the regenerating extensor digitorum longus muscle of immunosuppressed normal and mdx (dystrophin deficient) mice. Sections stained with X-gal and subjected to autoradiography permitted determination of the extent of nlsb-gal translocation in hybrid myofibers.Results: In vitro: All nuclei in G92% of hybrid myotubes showed evidence of nlsb-gal after exposure to X-gal, suggesting extensive translocation. Within hybrid myotubes, MM14-derived myonuclei D350 mm from a 3FlacZ10-derived myonucleus showed evidence of nlsb-gal. In vivo: Similar translocation of nlsb-gal was observed in vivo. One week after myoblast transfer, donor-derived myonuclei were distinguishable from hostderived myonuclei containing nlsb-gal by the greater accumulation of reaction product in donor myonuclei after X-gal staining. However, 2 weeks after injection, host myonuclei often contained a significant amount of nlsb-gal, and accumulation of reaction product could not be used as the criterion for identification of donor myonuclei.Conclusions: Translocation of nlsb-gal (or its mRNA) is significantly greater than previously reported (Ralston and Hall 1989), resulting in large numbers of nlsb-gal positive non-coding myonuclei in hybrid myofi-